Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by IFM Investors Pty Ltd

IFM Investors Pty Ltd lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,988 shares of the medical equipment provider's stock after buying an additional 6,061 shares during the quarter. IFM Investors Pty Ltd's holdings in Intuitive Surgical were worth $36,839,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of ISRG. Castleark Management LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after acquiring an additional 2,990 shares during the period. Arlington Trust Co LLC increased its stake in Intuitive Surgical by 34.5% in the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after buying an additional 191 shares during the period. Aaron Wealth Advisors LLC increased its stake in Intuitive Surgical by 3.2% in the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after buying an additional 78 shares during the period. Ewing Morris & Co. Investment Partners Ltd. acquired a new position in Intuitive Surgical in the 4th quarter valued at $454,000. Finally, Whalerock Point Partners LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $209,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the transaction, the executive vice president owned 5,224 shares in the company, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last 90 days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $7.71 on Monday, reaching $536.76. The stock had a trading volume of 349,661 shares, compared to its average volume of 1,667,715. The company has a market cap of $192.39 billion, a price-to-earnings ratio of 78.70, a P/E/G ratio of 5.78 and a beta of 1.64. The firm's fifty day moving average is $537.11 and its two-hundred day moving average is $536.92. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm earned $1.50 EPS. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent research reports. Barclays dropped their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Truist Financial dropped their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.